Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 4 Colorectal Neoplasms 4 Colonic Neoplasms 4 Lung Neoplasms 3 Lymphatic Metastasis 2 Venous Thrombosis 1 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Stage IV or Unresectable Gastric Cancer 1 Rectal Neoplasms 1 Pilonidal Sinus 1 Pancreatic Neuroendocrine Tumors 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pain 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Malignant Neoplasm of Transverse Colon 1 Locally Advanced Gastric Cancer 1 Kidney Neoplasms 1 Endometrial Neoplasms 1 Colorectal Liver Metastasis 1 Choledochal Cyst 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 779 Pemetrexed 606 Cisplatin 543 Paclitaxel 490 pembrolizumab 461 Docetaxel 440 Gemcitabine 328 Erlotinib Hydrochloride 307 Radiotherapy 255 Nivolumab 244 Bevacizumab 233 osimertinib 177 Drug Therapy 164 durvalumab 157 atezolizumab 135 Gefitinib 134 Radiosurgery 131 Vinorelbine 111 Cetuximab 97 130-nm albumin-bound paclitaxel 93 Ipilimumab 86 Magnetic Resonance Spectroscopy 83 Taxes 79 Surgical Procedures, Operative 74 Afatinib 68 Albumin-Bound Paclitaxel 66 Specimen Handling 61 Etoposide 61 Cyclophosphamide 60 tislelizumab 59

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × Conversion to Open Surgery × Clear all

NCT02360761 2016-09-20

STEPS

Peking University People's Hospital

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡